baber/WOPTO huggingface dataset:
Patent FI-895815-A0 (FI)
Inventor: CLARK DAVID ALAN
IPC: C07D263/38
Filed: 1989-12-05
Abstract: Oxazolidin-2-one derivs. of formula (I), corresp. pharmaceutically-acceptable acid addn. salt or pharmaceutically-acceptable cationic salt are new. Rb is (i), (ii) (iii) or (iv), W is S or O; X, X' is H, Cl, F or CF3; Y is -COOR1, -CON(R1)CH2CONR3R3, gp. (v) or vi), Ra, R1, R2, R3 are H, CH3, R4 is CH3 or CF3. For pharmaceutically-acceptable acid addn. salt, Y is gp. (v) or Rb is gp. (iii). For pharmaceutically-acceptable cationic salt y is -COOH or gp. (vi). - Also claimed is an optically active cpd. of formula (I) and use of cpd. (I) as a medicament for the treatment of hyperglycemia.
Patent FI-922968-A0 (FI)
Inventor: LESAGE JEAN-LUC
IPC: C03B23/035
Filed: 1992-06-26
Abstract: Process and device for bending a sheet of glass heated to bending temperature in a horizontal oven which it crosses conveyed by a conveyor with driving rollers (4) which conducts it into a bending cell (2) where an ambient temperature substantially identical with the bending temperature is maintained. The sheet of glass is immobilised in the bending cell under an upper bending mould (11) vertically above an annular countermould (21) surrounding a means for supporting the middle part of the sheet of glass in the bending cell, the said annular countermould (21) being raised to press the sheet of glass against the upper bending mould. The invention applies to the production of bent and optionally quenched motor vehicle glazing. <IMAGE>
Patent FI-923342-A0 (FI)
Inventor: MATOUS HEINRICH FRANZ
IPC: C07C323/26
Filed: 1992-07-22
Abstract: Complexes and pharmaceutical preparations containing complexes of the pleuromutilin derivative of formula I <CHEM> in free base or in acid addition or quaternary salt form and cyclodextrin are described. They can be prepared by complexing the above pleuromutilin compound with an appropriate cyclodextrin. They are indicated for use as pharmaceuticals, e.g. as antibiotics, especially in veterinary medicine, e.g. as feed additives.
Patent FI-925513-A0 (FI)
Inventor: SINCLAIR JOHN D
IPC: C07D489/08
Filed: 1992-12-04
Abstract: A method for treating alcoholism. The alcohol-drinking response of alcoholics is extinguished by having them drink alcoholic beverages while nalmefene, an opiate antagonist, blocks the positive reinforcement effect of ethanol in the brain.
Patent FI-925937-A0 (FI)
Inventor: SAGE JEAN-MARC
IPC: C08L77/10
Filed: 1992-12-30
Abstract: New polyamides comprising, on a mass basis:     a) 45 to 75 % of unit x,T, x being between 4 and 12; and b) 55 to 25 % of aliphatic unit -HN-(CH2)n-CO, n being between 6 and 14, and the terpolyamides obtained by including a monomer unit c) such as the unit 6 or 6,I as replacement for part of the aliphatic unit b). The polyamide compositions thus obtained have a Tg lower than 130 DEG C, a Tm higher than 230 DEG C and good crystallisability. <IMAGE>
Patent FI-932736-A0 (FI)
Inventor: AGMON GILAD
IPC: A23L11/30
Filed: 1993-06-15
Abstract: The present invention is concerned with a process for treating food products and by-products to remove therefrom off-flavours, off-colours, off-smells and undesirable impurities. The process comprises treating the food products and by-products, for example dairy products, soya products and by-products thereof, with adsorbent resin.
Patent FI-933810-A0 (FI)
Inventor: ARNOLD MACKLIN BRIAN
IPC: C07D413/12
Filed: 1993-08-31
Abstract: This invention provides novel decahydroisoquinoline compounds which are useful as excitatory amino acid receptor antagonists and in the treatment of neurological disorders. This invention also provides synthetic methods for preparing decahydroisoquinolines, as well as, novel intermediates in the synthesis thereof. The novel pharmaceutical compounds have the formula <CHEM>  wherein: R<1> is hydrogen, C1-C10 alkyl, arylalkyl, alkoxycarbonyl or acyl;  R<2> is hydrogen, C1-C6 alkyl, substituted alkyl, cycloalkyl, or arylalkyl;     R<3> is CO2H, SO3H, CONHSO2R<8>, or a group of formula <CHEM>   <CHEM>   <CHEM>     W is (CH2)n, S, SO, SO2;     Y is CHR<7>, NR<4>, O, S, SO, or SO2;     Z is NR<6>, CHR<7>, or CH; or W and Y together are HC=CH or C IDENTICAL C, or Y and Z together are HC=CH or C IDENTICAL C;     R<4> is hydrogen, C1-C4 alkyl, phenyl, or acyl; R<5> is hydrogen, C1-C4 alkyl, CF3, phenyl, hydroxy, amino, bromo, iodo, or chloro;     R<6> is acyl; R<7> is independently hydrogen, C1-C4 alkyl, phenyl, or substituted phenyl;     R<8> is C1-C4 alkyl or tetrazole-5-yl; and     n is 0, 1, or 2; provided that when Y is NR<4>, O, S, SO, or SO2, W is (CH2)n and Z is CHR<7> or CH; further provided that when W is S, SO, or SO2, Y is CHR<7>, Z is CHR<7> or CH, or Y and Z together are HC=CH or C IDENTICAL C;     further provided that when W and Z are CH2, Y is not S; further provided that when W and Y together are HC=CH or C IDENTICAL C, Z is CHR<7>; or a pharmaceutically acceptable salt thereof. 1,
Patent FI-934027-A0 (FI)
Inventor: BONNEAU LIONEL
IPC: C01F17/235
Filed: 1993-09-14
Abstract: New compositions based on ceric oxide exhibiting an improved ability to store oxygen, these compositions being characterised in that, besides ceric oxide, they contain at least one oxide of another metallic element M chosen from the group consisting of iron, bismuth, nickel, tin and chromium or one of their mixtures, this oxide being preferably in solid solution with the abovementioned cerium oxide. The process for the synthesis of these compositions consists in first of all preparing an intimate mixture of (i) a ceric oxide or hydroxide and (ii) at least one additive consisting of a hydroxide or a salt capable of being thermally decomposed to oxide, of the metallic element M, and in then calcining this mixture so as to obtain the desired oxide-based composition. The compositions according to the invention are particularly useful in the manufacture of catalysts and/or catalyst supports, especially those intended for the treatment of the exhaust gases of internal combustion engines.
Patent FI-940651-A0 (FI)
Inventor: DESMARAIS THOMAS ALLEN
IPC: C08F20/18
Filed: 1994-02-11
Abstract: Disclosed is a process for the continuous preparation of high internal phase emulsions which are suitable for subsequent polymerization into polymeric foam materials that, upon dewatering, act as absorbents for aqueous body fluids. The process involves continuous introduction of a certain type of monomer-containing oil phase and a certain type of electrolyte-containing water phase into a dynamic mixing zone at relatively low water to oil phase ratios. Flow rates are then steadily adjusted to increase the water to oil ratio of the streams fed to the dynamic mixing zone while subjecting the dynamic mixing zone contents to shear agitation which is sufficient to thereby form a high internal phase emulsion that, upon subsequent polymerization, provides a foam having an average cell size of from about 5 to 100 microns. The formation of such a stable high internal phase emulsion is completed by feeding the contents of the dynamic mixing zone to and through a static mixing zone.
Patent FI-943280-A0 (FI)
Inventor: WONG PATRICK S-L
IPC: A61K9/22
Filed: 1994-07-08
Abstract: The present invention is directed to a fluid-imbibing drug delivery device which is useful for the initial delayed delivery of an active agent formulation to a fluid environment of use, the initial delay period to startup or activation being of a predetermined length of time. The delivery of the agent formulation from the dispensing device, once begun, is continued over a predetermined prolonged period of time.
Patent FI-945364-A0 (FI)
Inventor: RAATIKAINEN JUKKA
IPC: G01N23/223
Filed: 1994-11-14
Abstract: PCT No. PCT/FI95/00621 Sec. 371 Date May 1, 1997 Sec. 102(e) Date May 1, 1997 PCT Filed Nov. 13, 1995 PCT Pub. No. WO96/15442 PCT Pub. Date May 23, 1996The invention relates to a method and an equipment for determining the content of an element from a flowing sample mass (1) by utilizing x-ray fluorescence, in which method the sample mass (1) is irradiated with x-ray or gamma radiation; the radiation emitted by the sample mass is detected; an energy-dispersive radiation spectrum of the radiation emitted by the sample mass is determined; and the content of the element is determined from the measured radiation spectrum on the basis of the intensity of the radiation spectrum window characteristic of this element. In order that the method and equipment would also be applicable in field conditions, the method farther comprises steps in which air temperature is measured in the air space between the sample mass (1) and a radiation detector or detectors (5); the first correction coefficient dependent on the measured air temperature is determined; and the determined content of the element is corrected by said first correction coefficient in order to compensate the attenuation of the characteristic radiation in the air between the sample mass (1) and the radiation detector or detectors (5).
Patent FI-951274-A0 (FI)
Inventor: LIHME ALLAN OTTO FOG
IPC: C07K14/47
Filed: 1995-03-17
Abstract: PCT No. PCT/DK93/00299 Sec. 371 Date Jul. 12, 1995 Sec. 102(e) Date Jul. 12, 1995 PCT Filed Sep. 17, 1993 PCT Pub. No. WO94/06822 PCT Pub. Date Mar. 31, 1994A method of isolating a biomolecule from a medium containing biomolecules by ion exchange wherein the ion exchange material consists of a material having ion exchanging groups which can be transformed from a charged form to an uncharged form; the eluant comprises a charge neutralizing acid or base transforming the ion exchanging groups from the charged form to the uncharged form; and the charge neutralizing acid or base has a concentration in the eluant which is twice, preferably equal to or less than the concentration of the ion exchanging groups of the ion exchange material; the ion exchange material being in a packed, hydrated state. Preferably the method is for the isolation of phosphopeptides from a medium containing casein hydrolysates and the use of such isolated biomolecules is for the production of a food, a feed, a health care product, a cosmetic, or a pharmaceutical.
Patent FI-964097-A0 (FI)
Inventor: SCHUETTE MANFRED-HEINRICH
IPC: A01N51/00
Filed: 1996-10-11
Abstract: PCT No. PCT/EP95/01222 Sec. 371 Date Oct. 7, 1996 Sec. 102(e) Date Oct. 7, 1996 PCT Filed Apr. 3, 1995 PCT Pub. No. WO95/28370 PCT Pub. Date Oct. 26, 1995The present invention relates to insecticidal fertilizer mixtures comprising a fertilizer component and an agonist or antagonist of the nicotinergic acetylcholine receptors of insects.
Patent FI-972225-A0 (FI)
Inventor: HALLENBECK PAUL L
IPC: A61K39/235
Filed: 1997-05-26
Abstract: The invention generally relates to targeted gene therapy using recombinant vectors and particularly adenovirus vectors. The invention specifically relates to replication-conditional vectors and methods for using them. Such vectors are able to selectively replicate in a target tissue to provide a therapeutic benefit from the presence of the vector per se or from heterologous gene products expressed from the vector and distributed throughout the tissue. In such vectors, a gene essential for replication is placed under the control of a heterologous tissue-specific transcriptional regulatory sequence. Thus, replication is conditioned on the presence of a factor(s) that induces transcription or the absence of a factor(s) that ihibits transcription of the gene by means of the transcriptional regulatory sequence with this vector; therefore, a target tissue can be selectively treated.
Patent FI-980302-A0 (FI)
Inventor: PALKISTO VIRPI
IPC: H04W8/06
Filed: 1998-02-10
Abstract: A support node (SGSN) in a packet radio network, the node being adapted to support mobile station location updates and data transmission to and/or from a mobile subscriber. A first address (IP1) has been appointed for the support node and it corresponds to the area served by the support node in the packet radio network. In addition, a second address (IP2) has been appointed to the support node (SGSN) and it belongs to the same address system as said first address (IP1). The second address (IP2) is used substantially for data transmission and . the first address (IP1) is used substantially for signaling outside data transmission. The area served by the support node is preferably divided into subareas, to each of which a second address (IP2) is appointed, and a mobile subscriber location update is informed to the home location register (HLR) only when the support node (SGSN) serving the mobile subscriber changes, but not when the subarea changes. The support node is preferably modular in such a way that there are a plurality of data transmission blocks (53), each of them serving a dedicated subarea and using its dedicated second address (IP2, IP2', IP2'').
Patent IL-69086-A0 (IL)
Title: Tylosin derivatives,processes for their production and pharmaceutical compositions containing them
IPC: A61K31/7048
Filed: 1983-06-27
Abstract: This invention relates to novel 23-demycinosyltylosin-derivatives possessing potent and broad spectrum anti-bacterial activity, processes for their preparation and pharmaceutical compositions containing them. 
<??>The compounds are of the general formula 
<CHEM>
 wherein
 R1 is hydrogen or acyl;
 R2 is acyl;
 R3 is hydrogen or acyl; or R2 and R3 are together a carbonyl group linking the 3 sec -and 4 sec -hydroxyl groups;
 R4 is hydrogen or acyl;
 R6 is methyl, hydroxymethyl, fluoromethyl, chloromethyl, bromomethyl, iodomethyl, di-(C1-C6)alkylaminomethyl, acyloxymethyl, CHO or a group of the formula CH=R5 wherein
 R5 is as hereinbelow defined; and
 Z is an iminogroup R5 or,
 when
 R6 is fluoromethyl, chloromethyl, bromomethyl, iodomethyl, acyloxymethyl, CHO, di(C1-C6)alkylaminomethyl,
 Z can also be oxo;
 and the pharmaceutically acceptable salts thereof.
Patent IL-80936-A0 (IL)
Title: Pharmaceutical compositions for inhibition of the 5-lipoxygenase pathway containing condensed imidazole derivatives,some new such compounds and their preparation
IPC: C07D487/04
Filed: 1986-12-10
Abstract: A diaryl-substituted imidazole fused to a thiazole, pyrrole, thiazine or pyridine ring, or pharmaceutical compositions thereof, are useful in inhibiting the 5-lipoxygenase pathway in an animal in need thereof by administration of an effective, 5-lipoxygenase pathway inhibiting amount of such compound.
Patent IL-83216-A0 (IL)
Title: Tetracyclic indole derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P9/12
Filed: 1987-07-16
Abstract: Compounds of the formula I : <CHEM>  wherein R1 =H, CH3; m = 0,1; R2 = R3 = H or R2, R3 = bond, R4 = C1-C4 hydrocarbon, n = 1 or 2 and their pharmaceutically acceptable salts are antihypertensive agents. Their preparation and pharmaceutical compositions containing them are also described.
Patent IL-88946-A0 (IL)
Title: Process for preparing 1-hydroxy-alkyl-2-methyl-5-nitroimidazoles
IPC: A61K31/415
Filed: 1989-01-12
Abstract: Process for preparing 1-(hydroxyalkyl)nitroimidazoles of formula: <IMAGE> (I)  which comprises reacting a sulphite or diacetate of an alkylenediol of formula: HO-(CH2)n-OH (II) in the presence of a strong acid (sulphuric acid) with an imidazole derivative of formula: <IMAGE> (III)  followed by hydrolizing or alcoholizing the product obtained. In the formulae (I) and (III), R denotes hydrogen or hydrocarbon. In the formulae (I) and (II), n is 2 or 3. In the formula (III), X denotes hydrogen or a radical which can be removed by hydrolysis or alcoholysis.
Patent IL-92069-A0 (IL)
Title: Contraception system and method
IPC: A61K31/57
Filed: 1989-10-20
Abstract: A method of contraception is disclosed which comprises a two-stage protocol. In the first stage, an estrogenic compound in a first composition is administered daily as the sole contraceptively active substance to a human female from about Day 2 to about Day 7 of her menstrual cycle, where Day 1 is the first day of menses. The second stage of the protocol occurs immediately thereafter during which at least one follow-up composition containing a progestin is administered daily to the same human female. The follow-up composition can contain a progestin as the sole contraceptively active ingredient, or can contain a combination of an estrogenic compound with a progestin in different weight ratios. A drug delivery system containing daily dosage units is also described.
Patent IL-97532-A0 (IL)
Title: Method for the synthesis of 5-carbamoyl-5h-dibenzo Úb,f¾ azepine
IPC: C07D223/22
Filed: 1991-03-12
Abstract: The invention relates to a process for the direct preparation of 5-carbamoyl-5H-dibenzo[b,f]azepine from iminostilbene which can be carried out readily on an industrial scale. 
<??>5-Carbamoyl-5H-dibenzo[b,f]azepine is of great importance as a pharmaceutical. 
<??>The essential feature of the invention consists in the fact that a hot solution of 5-chlorocarbonyl-5H-dibenzo[b,f]azepine which has been obtained in a known manner by phosgenation of iminostilbene in an inert aromatic solvent is buffered to a pH of 5-6, water is removed from the solution which has optionally been treated with active charcoal and then filtered, by azeotropic distillation, 100-110 % of the theoretical amount of NH3 is passed in at 70-105 DEG C under increased pressure, 10 to 40 % by weight of water, based on the original amount of 5-chlorocarbonyl-5H-dibenzo[b,f]azepine in the solution, are added after the reaction time, which causes the reaction mixture to become fluid due to very rapid changes in the crystal structure, which improves its stirrability greatly, a further 15-25 % of NH3 are finally passed in, and the mixture is allowed to after-react until the reaction is complete.
Patent SE-8900654-A0 (SE)
Title: Kemoelektrisk cell för vätgas och luft
Inventor: LINDSTRÖM O
IPC: H01M12/02
Filed: 1989-02-24
Abstract: AB 01le Lindstrom, Per Sundbergs vag 26, 183 63 Taby Manga produkter i vardagslivet utnyttjar elektriska stromkallor i form av primdrceller och sekundarceller for sin energifOrsorjning. Stromkallan svarar ofta for en stor del av produktens totalvikt. Elektrodmaterialen bestar av oxiderade och reducerade metallforeningar innehallande metaller sasom bly, nickel, kadmium, zink, mangan och kvicksilver. Dessa batterier bidrar idag till miljdfOrstoringen. Uppfinningen avser en tredje kemoelektrisk cell, namligen branslecellen. Elektrodmaterialen vatgas och loft ger en radikallosning pa det miljoproblem som idag ar associerat med smabatterierna. Den nya strOmkallan innehaller en cellsandwich bestaende av en hydrofob luftkatod (1), ett elektrolytskikt (2) och en vdtgasanod (3). Luftkatoden forsorjs med syre fran omgivande luft medan vatgasanoden
Patent SE-9904269-A0 (SE)
Title: Use of new responsive elements
Inventor: CLIMENT-JOHANSSON ISABEL
IPC: C12N15/85
Filed: 1999-11-25
Abstract: ABSTRACT The invention is related to the optimal DNA binding sites for the fork head transcription factors Afx, FKHR, and FKHRL1. This DNA binding sites for FKHR and FKHR11 share the core sequence GTAAA(C/T)A. The invention also relates to the use of the All identified response element in the screening for genes as diabetes drug targets and in the bioinformatic analysis of the human genome, finding a subset of genes transcriptionally responsive to insulin and in construction and development of assays enable and facilitating the analysis of genes interacting with the insulin receptor signaling pathway. Genes found in this screening can then be used in other screening methods for compounds modifmg the insulin receptor signaling pathway.
Patent AU-PQ703400-A0 (AU)
Title: Conveyor roller bearing housing
IPC: B65G39/09
Filed: 2000-04-19
Abstract: A polyurethane conveyor roller end cap internally houses rolling bearing and externally is interference-fitted into an end of a roller tube. The outside surface of the body of an end cap, although arranged in large part to engage the tube, has provided therein a circumferential line of blind recesses designed to minimize the amount of polyurethane used for the end cap while still allowing for the provision of load bearing column of polyurethane.
Patent FI-20001628-A0 (FI)
Inventor: HERRALA KALERVO
IPC: A01G1/00
Filed: 2000-07-07
Abstract: The invention relates to a method for producing clones of woody plants. According to the method, first, the mother plants are selected from selected clones in order to produce root cuttings and the mother plants are grown long enough to form a strong root system. After the growing period, the grown mother plants are left in dormancy and the shoots of the plants are cut after the plants have reached complete dormancy. The root system of the mother plant is recovered, the thinnest part of the root system is removed, and the roots are cut. The pieces of root, i.e., the root cuttings, are brought to rooting conditions to take root in a suitable growth medium or, optionally, the root cuttings are pre-treated. The root cuttings that have taken root and/or started to grow a shoot are selected, recovered, and grown to become plants. Alternatively, the root cuttings obtained from cutting or pre-treating the roots are selected and inserted directly into the selected area of forest cultivation.
Patent FI-20045254-A0 (FI)
Inventor: LANNES PETTERI
IPC: B65H18/22
Filed: 2004-06-30
Abstract: A method in a reeler and a reeler, wherein a reeling nip (N1) is formed by a reeling core (5) or a growing machine reel (R) and at least one loop of an endless supporting member (1), which is substantially continuous in the axial direction of the reeling core (5). In the method the tension profile of the endless supporting member (1) is determined from the measured variables proportional to the tension of the endless supporting member (1).
Patent FI-20065814-A0 (FI)
Inventor: SILVENNOINEN MARTTI
IPC: B23Q/
Filed: 2006-12-15
Abstract: The invention relates to a puller which is intended for moving a billet in a machine tool. The puller comprises a counter lug (12) and grappling devices (13) equipped with loading elements (15) for gripping a billet (14). The grappling devices (13) are adapted to be set in contact with the billet (14) with a puller movement substantially cross directional to the billet (14). The grappling devices (13) consist of two rollers (1) set non-rotatably to the puller, the two contact points (23) of which, formed with the billet (14), are adapted to be in the same line with the midpoint (24) of the billet (14). The invention also relates to a method for moving a billet in a machine tool.
Patent IL-109452-A0 (IL)
Title: Inhibition of leukocyte adhesion
IPC: A61P43/00
Filed: 1994-04-27
Abstract: This invention relates to the inhibition of intercellular adhesion mediated by L-selectin by administering a newly identified L-selectin ligand, CD34. More particularly, the invention concerns a method for inhibiting leukocyte adhesion to endothelial cells by administering an effective amount of an isolated, purified CD34 polypeptide or an antibody capable of binding native CD34.
Patent IL-111983-A0 (IL)
Title: Methods for producing protein c
Inventor: GRINNELL BRIAN WILLIAM
IPC: C12N15/63
Filed: 1994-12-14
Abstract: The present invention relates to a method for producing high levels of functional recombinant proteins in adenovirus-transformed mammalian cells by incubating cells capable of producing recombinant proteins at a temperature range between about 38 degrees centigrade and about 39 degrees centigrade. The method allows for higher levels of expression of total protein in some cell lines and higher levels of functional protein in other cell lines.